Company Filing History:
Years Active: 2020-2023
Title: Inventor Profile: Yuan-Chun Lo
Introduction
Yuan-Chun Lo is a prominent inventor based in New Taipei, Taiwan, recognized for his significant contributions to the field of neuropsychiatric treatment through innovative pharmaceutical formulations. With a total of four patents to his name, his work focuses primarily on the development of co-crystals that aim to address various mental health and metabolic disorders.
Latest Patents
Yuan-Chun Lo's latest patents include innovative formulas that utilize co-crystals of lithium benzoate and sodium benzoate. His patent on co-crystals of lithium benzoate outlines methods of preparing these co-crystals and their applications in treating neuropsychiatric disorders such as schizophrenia, psychotic disorders, depressive disorders, bipolar disorders, and neurogenerative disorders. Another significant patent pertains to co-crystals of sodium benzoate, which also addresses neuropsychiatric disorders and extends to metabolic disorders like obesity, diabetes, hypercholesterolemia, hypertension, and hyperlipidemia.
Career Highlights
Yuan-Chun Lo has established his professional career at Syneurx International (Taiwan) Corp., where he collaborates with other skilled professionals to advance research and development in pharmaceuticals. His impactful inventions have not only enriched the scientific community but have also paved the way for improved therapeutic strategies.
Collaborations
In his endeavors, Yuan-Chun Lo collaborates closely with esteemed colleagues like Guochuan Emil Tsai and Ching-Cheng Wang. Together, they contribute to a dynamic work environment that fosters innovation and the development of groundbreaking treatments.
Conclusion
Yuan-Chun Lo stands out as an influential inventor in the pharmaceutical industry, particularly in the realm of neuropsychiatric and metabolic disorder treatments. With his innovative patents and collaborative spirit, he continues to push the boundaries of what's possible in health care, aiming to improve the quality of life for individuals affected by complex mental and metabolic health challenges.